ACHFF (Arch Biopartners) Short-Term Debt : $1.98 Mil (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Arch Biopartners Short-Term Debt?

Arch Biopartners's Short-Term Debt for the quarter that ended in Dec. 2024 was $1.98 Mil.

Arch Biopartners's quarterly Short-Term Debt declined from Mar. 2024 ($3.29 Mil) to Sep. 2024 ($2.05 Mil) and declined from Sep. 2024 ($2.05 Mil) to Dec. 2024 ($1.98 Mil).

Arch Biopartners's annual Short-Term Debt increased from Sep. 2022 ($1.57 Mil) to Sep. 2023 ($3.19 Mil) but then declined from Sep. 2023 ($3.19 Mil) to Sep. 2024 ($2.05 Mil).

Arch Biopartners Short-Term Debt Historical Data

The historical data trend for Arch Biopartners's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Short-Term Debt Chart

Arch Biopartners Annual Data

Trend

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Sep24

Short-Term Debt

Get a 7-Day Free Trial

1.42

1.57

3.19

2.05

Arch Biopartners Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															3.19	3.38	3.29	2.05	1.98

Arch Biopartners Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Arch Biopartners Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

ARCH:Canada

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a late-stage clinical trial company focused on preventing acute kidney injury and organ damage caused by inflammation. The company is developing a platform of novel drugs that target the dipeptidase-1 (DPEP1) inflammation pathway, which is prevalent in the kidneys, lungs, and liver.